← Back
▼ SELL

$ Value

$26.0M

Shares

373,776

Price

$70

Filed

May 6

Insider

Name

ROBBINS LARRY

Title

CIK

0001228603

Roles

Director

Transaction Details

Transaction Date

2025-05-02

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

9,670,731

Footnotes

These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds"). | This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $67.08 to $68.07, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. | The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. | The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. | This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $68.08 to $69.0764, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. | This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $69.0817 to $70.035, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. | This price reflects the weighted average price for open-market sales of Shares on May 5, 2025 within a $1.00 range. The actual prices for these transactions range from $66.925 to $67.92, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. | This price reflects the weighted average price for open-market sales of Shares on May 5, 2025 within a $1.00 range. The actual prices for these transactions range from $67.925 to $68.26, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price. | This price reflects the weighted average price for open-market sales of Shares on May 6, 2025 within a $1.00 range. The actual prices for these transactions range from $66.235 to $67.05, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Filing Info

Accession No.

0000905148-25-001466

Form Type

4

Issuer CIK

0000064803

ROBBINS LARRY's History

Date Ticker Type Value
2025-12-11 BFLY $64K
2025-12-05 BFLY $611K
2025-12-04 BFLY $1.6M
2025-12-03 BFLY $2.4M
2025-11-21 BFLY $2.1M
2025-11-20 BFLY $2.4M
2025-11-20 CVS A $167K
2025-11-19 BFLY $2.4M
2025-06-13 BFLY A $0
2025-05-15 CVS A $168K

Other Insiders at CVS (90d)

Insider Bought Sold Last
Nelson Steven H
EVP and President, Aetna
$1K 2026-04-01
Joyner J. David
President, CEO and Chair
2026-04-01
Khichi Samrat S.
EVP, CPO and General Counsel
2026-04-01
CAPOZZI HEIDI B
EVP and Chief People Officer
2026-04-01
Compton-Phillips Amy
EVP, Chief Medical Officer
2026-03-31
Clark James David
SVP, Cont & Chief Acct Officer
2026-04-01
Newman Brian
EVP, Chief Financial Officer
2026-03-31
Mandadi Tilak
EVP, Chief Exp & Tech Officer
2026-04-01
Shah Prem S
EVP and Group President
2026-04-01